News Hansa Biopharma AB

Equities

HNSA

SE0002148817

Real-time Estimate Cboe Europe Other stock markets 07:28:00 26/06/2024 pm IST			5-day change	1st Jan Change
48.37 ^SEK	+3.80%		+15.82%	+84.96%

31/05	Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial	MT
31/05	Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hansa Biopharma publishes prospectus for admission to trading of shares on Nasdaq Stockholm	07/06	AQ
Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial	31/05	MT
Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial	31/05	AQ
Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial	31/05	CI
Notice to Annual General Meeting in Hansa Biopharma AB (publ)	27/05	AQ
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting	21/05	AQ
Hansa Biopharma to Present Data At 2024 American Transplant Congress Annual Meeting	21/05	CI
Correction, Hansa Biopharma, increase in number of shares and votes	06/05	AQ
Correction: Hansa Biopharma: increase in number of shares and votes	03/05	PU
Hansa Biopharma: increase in number of shares and votes	03/05	AQ
Hansa Biopharma Q1 - Improved European launch support	19/04	AQ
Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024	18/04
Hansa Biopharma interim report January-March 2024	18/04	AQ
Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04	CI
Hansa Biopharma Approves SEK372 Million Directed Share Issue	12/04	MT
Hansa Biopharma Announces Successful Execution of a Directed Share Issue of SEK 372 million (~USD 34.6 million)	12/04	AQ
Hansa Biopharma AB Provides Preliminary Unaudited Revenue Guidance for the First Quarter Ending March 31, 2024	02/04	CI
Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance	02/04	AQ
Hansa Biopharma publishes 2023 Annual and Sustainability Reports	21/03	AQ
Hansa Biopharma Hires New CFO	22/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hansa Biopharma AB

Equities

HNSA

SE0002148817

Summary

Filters